Selected research
Market Outlook & Growth Opportunities
Global In Vitro Testing Service Market Outlook and Growth Opportunities 2026
Market perspective
The global In Vitro Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for In Vitro Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for In Vitro Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for In Vitro Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the In Vitro Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the In Vitro Testing Service market include SGS, Intertek, Eurofins Scientific, Abich, XCellR8, ImQuest BioSciences, INVITRO-CONNECT, Covance and Bio-Rad Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global In Vitro Testing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of In Vitro Testing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents In Vitro Testing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global In Vitro Testing Service market.
In Vitro Testing Service Segment by Company
SGS
Intertek
Eurofins Scientific
Abich
XCellR8
ImQuest BioSciences
INVITRO-CONNECT
Covance
Bio-Rad Laboratories
Qiagen
GE Healthcare
Charles River Laboratories International
Catalent
Cyprotex
Promega
Gentronix Limited
Vimta Labs
In Vitro Testing Service Segment by Type
Biological Assays
Non-cell-based Assays
In Vitro Testing Service Segment by Application
Drug
Medical Device
Cosmetic
Others
In Vitro Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global In Vitro Testing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the In Vitro Testing Service key companies, revenue, market share, and recent developments.
3. To split the In Vitro Testing Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions In Vitro Testing Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify In Vitro Testing Service significant trends, drivers, influence factors in global and regions.
6. To analyze In Vitro Testing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vitro Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In Vitro Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vitro Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global In Vitro Testing Service industry.
Chapter 3: Detailed analysis of In Vitro Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of In Vitro Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of In Vitro Testing Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Biological Assays
- Non-cell-based Assays
Applications
- Drug
- Medical Device
- Cosmetic
- Others
Companies covered
- SGS
- Intertek
- Eurofins Scientific
- Abich
- XCellR8
- ImQuest BioSciences
- INVITRO-CONNECT
- Covance
- Bio-Rad Laboratories
- Qiagen
- GE Healthcare
- Charles River Laboratories International
- Catalent
- Cyprotex
- Promega
- Gentronix Limited
- Vimta Labs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global In Vitro Testing Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global In Vitro Testing Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 In Vitro Testing Service Market Dynamics
- 2.1 In Vitro Testing Service Industry Trends
- 2.2 In Vitro Testing Service Industry Drivers
- 2.3 In Vitro Testing Service Industry Opportunities and Challenges
- 2.4 In Vitro Testing Service Industry Restraints
3 In Vitro Testing Service Market by Company
- 3.1 Global In Vitro Testing Service Company Revenue Ranking in 2025
- 3.2 Global In Vitro Testing Service Revenue by Company (2021-2026)
- 3.3 Global In Vitro Testing Service Company Ranking (2024-2026)
- 3.4 Global In Vitro Testing Service Company Manufacturing Base and Headquarters
- 3.5 Global In Vitro Testing Service Company Product Type and Application
- 3.6 Global In Vitro Testing Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global In Vitro Testing Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 In Vitro Testing Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 In Vitro Testing Service Market by Type
- 4.1 In Vitro Testing Service Type Introduction
- 4.1.1 Biological Assays
- 4.1.2 Non-cell-based Assays
- 4.2 Global In Vitro Testing Service Sales Value by Type
- 4.2.1 Global In Vitro Testing Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global In Vitro Testing Service Sales Value by Type (2021-2032)
- 4.2.3 Global In Vitro Testing Service Sales Value Share by Type (2021-2032)
5 In Vitro Testing Service Market by Application
- 5.1 In Vitro Testing Service Application Introduction
- 5.1.1 Drug
- 5.1.2 Medical Device
- 5.1.3 Cosmetic
- 5.1.4 Others
- 5.2 Global In Vitro Testing Service Sales Value by Application
- 5.2.1 Global In Vitro Testing Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global In Vitro Testing Service Sales Value by Application (2021-2032)
- 5.2.3 Global In Vitro Testing Service Sales Value Share by Application (2021-2032)
6 In Vitro Testing Service Regional Value Analysis
- 6.1 Global In Vitro Testing Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global In Vitro Testing Service Sales Value by Region (2021-2032)
- 6.2.1 Global In Vitro Testing Service Sales Value by Region: 2021-2026
- 6.2.2 Global In Vitro Testing Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America In Vitro Testing Service Sales Value (2021-2032)
- 6.3.2 North America In Vitro Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe In Vitro Testing Service Sales Value (2021-2032)
- 6.4.2 Europe In Vitro Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific In Vitro Testing Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific In Vitro Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America In Vitro Testing Service Sales Value (2021-2032)
- 6.6.2 South America In Vitro Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa In Vitro Testing Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa In Vitro Testing Service Sales Value Share by Country, 2025 VS 2032
7 In Vitro Testing Service Country-level Value Analysis
- 7.1 Global In Vitro Testing Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global In Vitro Testing Service Sales Value by Country (2021-2032)
- 7.2.1 Global In Vitro Testing Service Sales Value by Country (2021-2026)
- 7.2.2 Global In Vitro Testing Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt In Vitro Testing Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt In Vitro Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt In Vitro Testing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 SGS
- 8.1.1 SGS Company Information
- 8.1.2 SGS Business Overview
- 8.1.3 SGS In Vitro Testing Service Revenue and Gross Margin (2021-2026)
- 8.1.4 SGS In Vitro Testing Service Product Portfolio
- 8.1.5 SGS Recent Developments
- 8.2 Intertek
- 8.2.1 Intertek Company Information
- 8.2.2 Intertek Business Overview
- 8.2.3 Intertek In Vitro Testing Service Revenue and Gross Margin (2021-2026)
- 8.2.4 Intertek In Vitro Testing Service Product Portfolio
- 8.2.5 Intertek Recent Developments
- 8.3 Eurofins Scientific
- 8.3.1 Eurofins Scientific Company Information
- 8.3.2 Eurofins Scientific Business Overview
- 8.3.3 Eurofins Scientific In Vitro Testing Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Eurofins Scientific In Vitro Testing Service Product Portfolio
- 8.3.5 Eurofins Scientific Recent Developments
- 8.4 Abich
- 8.4.1 Abich Company Information
- 8.4.2 Abich Business Overview
- 8.4.3 Abich In Vitro Testing Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Abich In Vitro Testing Service Product Portfolio
- 8.4.5 Abich Recent Developments
- 8.5 XCellR8
- 8.5.1 XCellR8 Company Information
- 8.5.2 XCellR8 Business Overview
- 8.5.3 XCellR8 In Vitro Testing Service Revenue and Gross Margin (2021-2026)
- 8.5.4 XCellR8 In Vitro Testing Service Product Portfolio
- 8.5.5 XCellR8 Recent Developments
- 8.6 ImQuest BioSciences
- 8.6.1 ImQuest BioSciences Company Information
- 8.6.2 ImQuest BioSciences Business Overview
- 8.6.3 ImQuest BioSciences In Vitro Testing Service Revenue and Gross Margin (2021-2026)
- 8.6.4 ImQuest BioSciences In Vitro Testing Service Product Portfolio
- 8.6.5 ImQuest BioSciences Recent Developments
- 8.7 INVITRO-CONNECT
- 8.7.1 INVITRO-CONNECT Company Information
- 8.7.2 INVITRO-CONNECT Business Overview
- 8.7.3 INVITRO-CONNECT In Vitro Testing Service Revenue and Gross Margin (2021-2026)
- 8.7.4 INVITRO-CONNECT In Vitro Testing Service Product Portfolio
- 8.7.5 INVITRO-CONNECT Recent Developments
- 8.8 Covance
- 8.8.1 Covance Company Information
- 8.8.2 Covance Business Overview
- 8.8.3 Covance In Vitro Testing Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Covance In Vitro Testing Service Product Portfolio
- 8.8.5 Covance Recent Developments
- 8.9 Bio-Rad Laboratories
- 8.9.1 Bio-Rad Laboratories Company Information
- 8.9.2 Bio-Rad Laboratories Business Overview
- 8.9.3 Bio-Rad Laboratories In Vitro Testing Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Bio-Rad Laboratories In Vitro Testing Service Product Portfolio
- 8.9.5 Bio-Rad Laboratories Recent Developments
- 8.10 Qiagen
- 8.10.1 Qiagen Company Information
- 8.10.2 Qiagen Business Overview
- 8.10.3 Qiagen In Vitro Testing Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Qiagen In Vitro Testing Service Product Portfolio
- 8.10.5 Qiagen Recent Developments
- 8.11 GE Healthcare
- 8.11.1 GE Healthcare Company Information
- 8.11.2 GE Healthcare Business Overview
- 8.11.3 GE Healthcare In Vitro Testing Service Revenue and Gross Margin (2021-2026)
- 8.11.4 GE Healthcare In Vitro Testing Service Product Portfolio
- 8.11.5 GE Healthcare Recent Developments
- 8.12 Charles River Laboratories International
- 8.12.1 Charles River Laboratories International Company Information
- 8.12.2 Charles River Laboratories International Business Overview
- 8.12.3 Charles River Laboratories International In Vitro Testing Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Charles River Laboratories International In Vitro Testing Service Product Portfolio
- 8.12.5 Charles River Laboratories International Recent Developments
- 8.13 Catalent
- 8.13.1 Catalent Company Information
- 8.13.2 Catalent Business Overview
- 8.13.3 Catalent In Vitro Testing Service Revenue and Gross Margin (2021-2026)
- 8.13.4 Catalent In Vitro Testing Service Product Portfolio
- 8.13.5 Catalent Recent Developments
- 8.14 Cyprotex
- 8.14.1 Cyprotex Company Information
- 8.14.2 Cyprotex Business Overview
- 8.14.3 Cyprotex In Vitro Testing Service Revenue and Gross Margin (2021-2026)
- 8.14.4 Cyprotex In Vitro Testing Service Product Portfolio
- 8.14.5 Cyprotex Recent Developments
- 8.15 Promega
- 8.15.1 Promega Company Information
- 8.15.2 Promega Business Overview
- 8.15.3 Promega In Vitro Testing Service Revenue and Gross Margin (2021-2026)
- 8.15.4 Promega In Vitro Testing Service Product Portfolio
- 8.15.5 Promega Recent Developments
- 8.16 Gentronix Limited
- 8.16.1 Gentronix Limited Company Information
- 8.16.2 Gentronix Limited Business Overview
- 8.16.3 Gentronix Limited In Vitro Testing Service Revenue and Gross Margin (2021-2026)
- 8.16.4 Gentronix Limited In Vitro Testing Service Product Portfolio
- 8.16.5 Gentronix Limited Recent Developments
- 8.17 Vimta Labs
- 8.17.1 Vimta Labs Company Information
- 8.17.2 Vimta Labs Business Overview
- 8.17.3 Vimta Labs In Vitro Testing Service Revenue and Gross Margin (2021-2026)
- 8.17.4 Vimta Labs In Vitro Testing Service Product Portfolio
- 8.17.5 Vimta Labs Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst